Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/305225 
Authors: 
Year of Publication: 
2024
Series/Report no.: 
I4R Discussion Paper Series No. 177
Publisher: 
Institute for Replication (I4R), s.l.
Abstract: 
Atwood (2022b) reports a positive effect of the 1963 measles vaccine on long-run economic outcomes. The identifying variation is from pre-vaccine average reported measles incidence, but this plausibly represents reporting capacity or initial health levels, rather than actual disease incidence. I extend the sample and use an event study to test for differential trends, and find trends that are inconsistent with a treatment effect of the vaccine.
JEL: 
I12
I18
J22
J24
J31
Document Type: 
Working Paper

Files in This Item:
File
Size





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.